The global metagenomics market was valued at $176 million in 2017 and is expected to reach $523 million by 2024 at a CAGR of 16.8% during the forecast period. Metagenomics is the study of genomes collectively in a microbial community. This process involves cloning and analyzing the genomes without culturing the organisms in the community.
Increase in advancements regarding DNA sequencing and rise in expansion of metagenomics applications drive the growth of the global metagenomics market. However, dearth of skilled professionals coupled with the rise in concerns regarding standardization and accuracy of sequencing based diagnostic testing hampers the market growth. Moreover, developing nations offer profitable opportunities for metagenomic sequencing product manufacturers.
The global metagenomics market is segmented based on technology, product, application, and region. Based on technology, the market is bifurcated into sequencing and bioinformatics. By product, the market is divided into instrument & software and consumable. On the basis of application, the market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. As per region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global metagenomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry from 2017 to 2024 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps to understand the applications and technologies used globally.
The key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
Instrument & software
Consumable
By Technology
Sequencing
Bioinformatics
By Application
Infectious disease diagnosis
Environmental remediation
Gut microbe characterization
Biotechnology
Biofuel
Agriculture
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Agilent Technologies, Inc.
Enterome SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Swift Biosciences, Inc.
Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report):
Siemens AG
ZS Genetics, Inc.
Abbott Laboratories
Beckman Coulter
LI-COR
Genomatix GmbH
Beijing Genomics Institute
Pieriandx
Increase in advancements regarding DNA sequencing and rise in expansion of metagenomics applications drive the growth of the global metagenomics market. However, dearth of skilled professionals coupled with the rise in concerns regarding standardization and accuracy of sequencing based diagnostic testing hampers the market growth. Moreover, developing nations offer profitable opportunities for metagenomic sequencing product manufacturers.
The global metagenomics market is segmented based on technology, product, application, and region. Based on technology, the market is bifurcated into sequencing and bioinformatics. By product, the market is divided into instrument & software and consumable. On the basis of application, the market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. As per region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global metagenomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry from 2017 to 2024 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps to understand the applications and technologies used globally.
The key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
Instrument & software
Consumable
By Technology
Sequencing
Bioinformatics
By Application
Infectious disease diagnosis
Environmental remediation
Gut microbe characterization
Biotechnology
Biofuel
Agriculture
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Agilent Technologies, Inc.
Enterome SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Swift Biosciences, Inc.
Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report):
Siemens AG
ZS Genetics, Inc.
Abbott Laboratories
Beckman Coulter
LI-COR
Genomatix GmbH
Beijing Genomics Institute
Pieriandx
Frequently Asked Questions about the Global Metagenomics Market
What is the estimated value of the Global Metagenomics Market?
What is the growth rate of the Global Metagenomics Market?
What is the forecasted size of the Global Metagenomics Market?
Note: Product cover images may vary from those shown
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: METAGENOMICS MARKET, BY TECHNOLOGY
CHAPTER 5: METAGENOMICS MARKET, BY PRODUCT
CHAPTER 6: METAGENOMICS MARKET, BY APPLICATION
CHAPTER 7: METAGENOMICS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Note: Product cover images may vary from those shown
According to a new report titled, Metagenomics Market by Product, Technology, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2024, the global metagenomics market was valued at $176 million in 2017 and is expected to reach $523 million by 2024 at a CAGR of 16.8% during the forecast period. The bioinformatics segment accounted for one-fifth of the total market share in 2017.
Metagenomics is a relatively new field, which comprises the analysis of collective genomes of the members of the microbial community along with studying the interaction of microbes. In addition, metagenomic technologies enable the study of microbial communities as entire units without entailing the need of cultivating them. As non-cultivability and genomic diversity serve as the two major roadblocks in the advancements of environmental and clinical microbiology, metagenomics has gained immense traction among healthcare professionals and researchers.
In addition, rise in technological advancements regarding DNA sequencing is anticipated to drive the demand for metagenomic studies across the globe. Advancements in the same are highly focused towards the development of DNA sequencing platforms. Moreover, considerable expansion of metagenomic applications over the years has supplemented the market growth. The consumable segment generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the high adoption of consumables in pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol. This step comprises sample preparation, sample processing, and metagenomic sequencing.
The instrument & software segment is expected to register the highest growth rate during the forecast period. Several instruments and software are employed across metagenomic analysis, sequencing, sequence binning, annotation, taxonomic classification, statistical analysis, and data storage & sharing.
Based on application, the global metagenomics market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. The gut microbe characterization segment has dominated the global market in 2017 and is expected to maintain this dominance throughout the forecast period. Whereas, the infectious disease diagnosis segment has registered the fastest growth rate throughout the forecast period. The two common metagenomics methods used in the identification of infectious disease diagnosis include deep amplicon sequencing and whole-genome shotgun metagenomics.
Key Findings of the Metagenomics Market:
The sequencing segment accounted for four-fifths of the total market share in 2017.
The environmental remediation segment registered the second-highest growth rate among applications with a CAGR of 17.4% from 2018 to 2024.
North America dominated the global metagenomics market, accounting for the maximum share in 2017, and is expected to retain the same trend during the forecast period.
India has registered the highest growth rate in the Asia-Pacific metagenomics market with a CAGR of 19.7% during the forecast period.
Germany accounted for two-sevenths of the total share in the European metagenomics market in 2017.
The Asia-Pacific region is expected to witness the highest growth rate throughout the forecast period, owing to its high population base, surge in disposable income, and rise in awareness towards new sequencing technologies. In addition, potential collaborations between the developed and developing economies working in the field of microbiome and metagenomics are the key contributors for the market growth in this region.
The major companies profiled in this report include Agilent Technologies, Inc., Enterome SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Qiagen N.V., Swift Biosciences, Inc., and Thermo Fisher Scientific, Inc. The other players operating in the global metagenomics market include Siemens AG, ZS Genetics, Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing Genomics Institute, and Pieriandx.
Metagenomics is a relatively new field, which comprises the analysis of collective genomes of the members of the microbial community along with studying the interaction of microbes. In addition, metagenomic technologies enable the study of microbial communities as entire units without entailing the need of cultivating them. As non-cultivability and genomic diversity serve as the two major roadblocks in the advancements of environmental and clinical microbiology, metagenomics has gained immense traction among healthcare professionals and researchers.
In addition, rise in technological advancements regarding DNA sequencing is anticipated to drive the demand for metagenomic studies across the globe. Advancements in the same are highly focused towards the development of DNA sequencing platforms. Moreover, considerable expansion of metagenomic applications over the years has supplemented the market growth. The consumable segment generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the high adoption of consumables in pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol. This step comprises sample preparation, sample processing, and metagenomic sequencing.
The instrument & software segment is expected to register the highest growth rate during the forecast period. Several instruments and software are employed across metagenomic analysis, sequencing, sequence binning, annotation, taxonomic classification, statistical analysis, and data storage & sharing.
Based on application, the global metagenomics market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. The gut microbe characterization segment has dominated the global market in 2017 and is expected to maintain this dominance throughout the forecast period. Whereas, the infectious disease diagnosis segment has registered the fastest growth rate throughout the forecast period. The two common metagenomics methods used in the identification of infectious disease diagnosis include deep amplicon sequencing and whole-genome shotgun metagenomics.
Key Findings of the Metagenomics Market:
The sequencing segment accounted for four-fifths of the total market share in 2017.
The environmental remediation segment registered the second-highest growth rate among applications with a CAGR of 17.4% from 2018 to 2024.
North America dominated the global metagenomics market, accounting for the maximum share in 2017, and is expected to retain the same trend during the forecast period.
India has registered the highest growth rate in the Asia-Pacific metagenomics market with a CAGR of 19.7% during the forecast period.
Germany accounted for two-sevenths of the total share in the European metagenomics market in 2017.
The Asia-Pacific region is expected to witness the highest growth rate throughout the forecast period, owing to its high population base, surge in disposable income, and rise in awareness towards new sequencing technologies. In addition, potential collaborations between the developed and developing economies working in the field of microbiome and metagenomics are the key contributors for the market growth in this region.
The major companies profiled in this report include Agilent Technologies, Inc., Enterome SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Qiagen N.V., Swift Biosciences, Inc., and Thermo Fisher Scientific, Inc. The other players operating in the global metagenomics market include Siemens AG, ZS Genetics, Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing Genomics Institute, and Pieriandx.
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
